PUBLISHED FOR OPPOSITION
on 17 Dec 2024
Last Applicant/ Owned by
1538 Main North Road
SALISBURY SOUTH SA
AU
5106
Serial Number
98376011 filed on 25th Jan 2024
Registration Number
N/A
Correspondent Address
Melissa A. Nowak
Filing Basis
1. intent to use current
2. filed as use application
3. use application currently
Disclaimer
NO DATA
MAYNE PHARMA
Research and development services relating to chemical and pharmaceutical products; pharmaceutical formulation development services; research and development services relating to pharmaceutical manufacturing processes; testing services related to chemical and pharmaceutical products manufacture, namely, quality control testing for others, batch stability and validation testing contraceptive appar Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development services relating to chemical and pharmaceutical products; pharmaceutical formulation development services; research and development services relating to pharmaceutical manufacturing processes; testing services related to chemical and pharmaceutical products manufacture, namely, quality control testing for others, batch stability and validation testing
First Use Date in General
01st Jan 2004
First Use Date in Commerce
01st Aug 2014
Class [010]
Medical Instrument Products
contraceptive apparatus in the field of gynecology and women's health
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Contract manufacturing being custom manufacturing of chemical and pharmaceutical products including solid oral and liquid dosage forms and topical liquid and cream formulations
First Use Date in General
01st Jan 2004
First Use Date in Commerce
01st Aug 2014
Class [005]
Pharmaceutical Products
Pharmaceutical preparations in the field of gynecology and women's health, namely, contraceptive preparations and oral contraceptives; hormone replacement therapy preparations containing estradiol and progesterone for use in treating the symptoms associated with menopause; pharmaceutical preparations for the treatment of vulval vaginal atrophy; antibiotic preparations; pharmaceutical preparations for the treatment of dermatological diseases and disorders; topical foam pharmaceutical preparations for treatment of steroid responsive dermatoses; pharmaceutical preparations for the treatment of rosacea and erythema associated with rosacea; pharmaceutical preparations for the treatment of psoriasis; antifungal preparations; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical substances and preparations for the treatment of cancer; dietary and nutritional supplements; vitamins
First Use Date in General
27th Apr 2018
First Use Date in Commerce
27th Apr 2018
Mark Details
Serial Number
No 98376011
Mark Type
No Service Mark
Attorney Docket Number
No 2830-T81US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.21 -
Circles that are totally or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 17th Dec 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 17th Dec 2024 | PUBLISHED FOR OPPOSITION |
| 11th Dec 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 03rd Dec 2024 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 19th Nov 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 19th Nov 2024 | EXAMINERS AMENDMENT E-MAILED |
| 19th Nov 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 19th Nov 2024 | EXAMINER'S AMENDMENT ENTERED |
| 19th Nov 2024 | EXAMINERS AMENDMENT -WRITTEN |
| 29th Oct 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |